Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease

Multiple Sclerosis Journal

Volumn 20, Issue 8, 2014, Pages 1135-1139

  Zéphir, Hélène ^a,b   Gower Rousseau, Corinne ^c   Salleron, Julia ^d   Simon, Olivier ^a   Debouverie, Marc ^e   Le Page, Emmanuelle ^f   Bouhnik, Yoram ^g   Lebrun Frenay, Christine ^h   Papeix, Caroline ⁱ   Vigneron, Benoît ^a   Allez, Matthieu ^j   Prin, Lionel ^b   Cosnes, Jacques ^k   Vermersch, Patrick ^a,b   Colombel, Jean Frédéric ^a,l  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Lille Hospital   (France)

^d INSERM   (France)

^e Hopital Central   (France)

^f Department of Neurology CHU Centre Hospitalier Universitaire   (France)

^g BEAUJON HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ Department of Neurology Salptrire Hospital   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k HÔPITAL SAINT ANTOINE   (France)

^l MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

colitis; epidemiology; Multiple sclerosis; prognosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; SCORING SYSTEM; CASE CONTROL STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISABILITY; FRANCE; IMMUNOLOGY; PROGNOSIS; PROTECTION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; FRANCE; HUMANS; MALE; MULTIPLE SCLEROSIS; PROGNOSIS; PROTECTIVE FACTORS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84904821411     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513515081     Document Type: Article

References (10)

1. Kimura K, Hunter SF, Thollander MS, et al. Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clin Proc. 2000 ; 75: 802-806 (Pubitemid 30640638)
2. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study. Gastroenterology. 2005 ; 129: 827-836 (Pubitemid 41242675)
3. Nielsen NM, Frisch M, Rostgaard K, et al. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: A nationwide cohort study in Denmark. Mult Scler. 2008 ; 14: 823-829
4. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol. 2005 ; 58: 840-846 (Pubitemid 41746873)
5. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994 ; 35: 1433-1438 (Pubitemid 24310907)
6. Leray E, Yaouanq J, Le Page E, et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain. 2010 ; 133: 1900-1913
7. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002 ; 8: 244-250 (Pubitemid 34784976)
8. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel diseases: Controversies, consensus and implications. Gut. 2006 ; 55: 749-753 (Pubitemid 43764536)
9. Loftus EV, Harewood GC, Loftus CG, et al. PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005 ; 54: 91-96 (Pubitemid 40007225)
10. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide expression. J Immunol. 2010 ; 185: 4101-4108